KovaDx

company

About

KovaDx is bridging the health disparity faced by people with sickle cell disease, as well as, other hemolytic anemias.

  • 1 - 10

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$100K
Industries
Artificial Intelligence,Health Care,Machine Learning
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Millions of people suffer from Sickle Cell Disease and other hemolytic anemias. KovaDx is making healthcare accessible to these individuals by providing an affordable and easy to use point-of-care solution. Our system is based on Quantitative Phase Imaging and uses deep learning to make predictions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$356K
KovaDx has raised a total of $356K in funding over 2 rounds. Their latest funding was raised on Aug 10, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 10, 2021 Grant $256K 1 National Science Foundation Detail
Oct 1, 2020 Pre-seed $100K 1 EXPERT DOJO Detail

Investors

Number of Lead Investors
Number of Investors
2
2
KovaDx is funded by 2 investors. National Science Foundation and EXPERT DOJO are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
EXPERT DOJO Yes Pre-seed